Adamas Pharmaceuticals Inc's

Name: Adamas Pharmaceuticals Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ADMS Sales vs. its Competitors Q3 2019

Comparing the current results to its competitors, Adamas Pharmaceuticals Inc reported Revenue increase in the 3 quarter 2019 by 31.28 % year on year.
The revenue growth was below Adamas Pharmaceuticals Inc's competitors' average revenue growth of 34.82 %, achieved in the same quarter.

• List of ADMS Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Adamas Pharmaceuticals Inc recorded a net loss, as well as most of its competitors.

<< ADMS Stock Performance Comparisons

<< See the full list of ADMS competitors

Overall company Market Share Q3 2019

Contrary to strong revenue growth of 31.28 % in Overall company, Adamas Pharmaceuticals Inc has lost market share within this division. << More on ADMS Market Share.

*Market share is calculated based on total revenue.

ADMS's Stock Performance relative to its Competitors

Publicly Traded Peers of Adamas Pharmaceuticals Inc

Peak Pharmaceuticals Inc
Share Performance

-15.13%

This Quarter

Peak Pharmaceuticals Inc

Profile

Peak Pharmaceuticals Inc's business model involves the development, manufacturing, and distribution of pharmaceutical products.

More about Peak Pharmaceuticals Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 4.396 mill.	$ - mill.	$ -0.272 mill.

Seelos Therapeutics inc
Share Performance

-98.23%

This Year

Seelos Therapeutics inc

Profile

Seelos Therapeutics Inc. is a biopharmaceutical company with a focus on developing innovative therapies for central nervous system disorders. They operate on a research-based business model, leveraging scientific advancements to discover and develop novel treatment options. Their goal is to address unmet medical needs in conditions such as Parkinson's disease, Sanfilippo syndrome, and other severe neurological disorders.

More about Seelos Therapeutics inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 0.981 mill.	$ 2.072 mill.	$ 4.091 mill.

Sources: Adamas Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Monday, August 31, 2026 5:56 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Adamas Pharmaceuticals Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.